Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKinsey
Dow
Boehringer Ingelheim
Harvard Business School

Last Updated: December 7, 2021

Volunteer for clinical trials for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE at ClinicalTrialExchange

DrugPatentWatch Database Preview

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Diphenoxylate Hydrochloride And Atropine Sulfate, and when can generic versions of Diphenoxylate Hydrochloride And Atropine Sulfate launch?

Diphenoxylate Hydrochloride And Atropine Sulfate is a drug marketed by Hikma Pharms, Able, Ani Pharms, Ascot, Bayshore Pharms Llc, Fosun Pharma, Heather, Hikma, Inwood Labs, Kv Pharm, Lannett, Leading Pharma Llc, Lederle, Mayne Pharma Inc, Mylan, Par Pharm, Parke Davis, Pharma Life, Pvt Form, R And S Pharma, Roxane, Specgx Llc, Sun Pharm Industries, Upsher Smith Labs, Usl Pharma, Valeant Pharm Intl, Watson Labs, and Winder Labs Llc. and is included in twenty-eight NDAs.

The generic ingredient in DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.

Summary for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
US Patents:0
Applicants:28
NDAs:28
Finished Product Suppliers / Packagers: 20
Clinical Trials: 1
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE?DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE excipients list
DailyMed Link:DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE at DailyMed
Drug patent expirations by year for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
Recent Clinical Trials for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Puma Biotechnology, Inc.Phase 2
Napo Pharmaceuticals, Inc.Phase 2
University of California, San FranciscoPhase 2

See all DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE clinical trials

Pharmacology for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE

US Patents and Regulatory Information for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Winder Labs Llc DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 211362-001 Jan 27, 2021 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma Pharms DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride SOLUTION;ORAL 087708-001 May 3, 1982 RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pharma Life DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 207128-001 Oct 21, 2020 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Upsher Smith Labs DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 210571-001 Aug 31, 2018 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Harvard Business School
Medtronic
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.